Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors | ||
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología | |
| dc.conicet.organizacion | Medical Research Center | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Kantonsspital St. Gallen | |
| dc.conicet.organizacion | Medical Research Center | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Medical Research Center | |
| dc.conicet.organizacion | Medical Research Center | |
| dc.conicet.organizacion | Kantonsspital St. Gallen | |
| dc.conicet.organizacion | Kantonsspital St. Gallen | |
| dc.conicet.organizacion | Kantonsspital St. Gallen | |
| dc.conicet.organizacion | Universitat Erlangen-Nuremberg | |
| dc.conicet.organizacion | Universitat Erlangen-Nuremberg | |
| dc.conicet.organizacion | Ludwig Maximilians Universitat | |
| dc.conicet.organizacion | Ludwig Maximilians Universitat | |
| dc.conicet.organizacion | Universitat Erlangen-Nuremberg | |
| dc.conicet.organizacion | Kantonsspital St Gallen | |
| dc.conicet.organizacion | Krankenhaus Nordwest | |
| dc.conicet.organizacion | German Cancer Research Center | |
| dc.conicet.organizacion | German Cancer Research Center | |
| dc.conicet.organizacion | German Cancer Research Center | |
| dc.conicet.organizacion | Universitat Bonn | |
| dc.conicet.organizacion | Universitat Bonn | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Istituto Nazionale Tumori | |
| dc.conicet.organizacion | Istituto Nazionale Tumori | |
| dc.conicet.organizacion | Bursa Uludag University | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | University Hospital Tübingen | |
| dc.conicet.organizacion | Eberhard Karls Universität Tübingen | |
| dc.conicet.organizacion | University of British Columbia | |
| dc.conicet.organizacion | Kantonsspital St Gallen | |
| dc.conicet.organizacion | Universitat Zurich | |
| dc.conicet.organizacion | Kantonsspital St Gallen | |
| dc.conicet.organizacion | Tel Aviv University | |
| dc.contributor.author | Núñez, Nicolás | |
| dc.contributor.author | Berner, Fiamma | |
| dc.contributor.author | Friebel, Ekaterina | |
| dc.contributor.author | Unger, Susanne | |
| dc.contributor.author | Wyss, Nina | |
| dc.contributor.author | Martinez Gomez, Julia | |
| dc.contributor.author | Purde, Mette Triin | |
| dc.contributor.author | Niederer, Rebekka | |
| dc.contributor.author | Porsch, Maximilian | |
| dc.contributor.author | Lichtensteiger, Christa | |
| dc.contributor.author | Kramer, Rafaela | |
| dc.contributor.author | Erdmann, Michael | |
| dc.contributor.author | Schmitt, Christina | |
| dc.contributor.author | Heinzerling, Lucie | |
| dc.contributor.author | Abdou, Marie Therese | |
| dc.contributor.author | Karbach, Julia | |
| dc.contributor.author | Schadendorf, Dirk | |
| dc.contributor.author | Zimmer, Lisa | |
| dc.contributor.author | Ugurel, Selma | |
| dc.contributor.author | Klümper, Niklas | |
| dc.contributor.author | Hölzel, Michael | |
| dc.contributor.author | Power, Laura | |
| dc.contributor.author | Kreutmair, Stefanie | |
| dc.contributor.author | Capone, Mariaelena | |
| dc.contributor.author | Madonna, Gabriele | |
| dc.contributor.author | Cevhertas, Lacin | |
| dc.contributor.author | Heider, Anja | |
| dc.contributor.author | Amaral, Teresa | |
| dc.contributor.author | Hasan Ali, Omar | |
| dc.contributor.author | Bomze, David | |
| dc.date.issued | 2023-02 | |
| dc.description.abstract | Background: Immune checkpoint inhibitors (ICIs) are among the most promising treatment options for melanoma and non-small cell lung cancer (NSCLC). While ICIs can induce effective anti-tumor responses, they may also drive serious immune-related adverse events (irAEs). Identifying biomarkers to predict which patients will suffer from irAEs would enable more accurate clinical risk-benefit analysis for ICI treatment and may also shed light on common or distinct mechanisms underpinning treatment success and irAEs. Methods: In this prospective multi-center study, we combined a multi-omics approach including unbiased single-cell profiling of over 300 peripheral blood mononuclear cell (PBMC) samples and high-throughput proteomics analysis of over 500 serum samples to characterize the systemic immune compartment of patients with melanoma or NSCLC before and during treatment with ICIs. Findings: When we combined the parameters obtained from the multi-omics profiling of patient blood and serum, we identified potential predictive biomarkers for ICI-induced irAEs. Specifically, an early increase in CXCL9/CXCL10/CXCL11 and interferon-γ (IFN-γ) 1 to 2 weeks after the start of therapy are likely indicators of heightened risk of developing irAEs. In addition, an early expansion of Ki-67+ regulatory T cells (Tregs) and Ki-67+ CD8+ T cells is also likely to be associated with increased risk of irAEs. Conclusions: We suggest that the combination of these cellular and proteomic biomarkers may help to predict which patients are likely to benefit most from ICI therapy and those requiring intensive monitoring for irAEs. Funding: This work was primarily funded by the European Research Council, the Swiss National Science Foundation, the Swiss Cancer League, and the Forschungsförderung of the Kantonsspital St. Gallen. | es |
| dc.description.fil | Fil: Núñez, Nicolás. Universitat Zurich; Suiza. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina | |
| dc.description.fil | Fil: Berner, Fiamma. Medical Research Center; Suiza | |
| dc.description.fil | Fil: Friebel, Ekaterina. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Unger, Susanne. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Wyss, Nina. Kantonsspital St. Gallen; Suiza. Medical Research Center; Suiza | |
| dc.description.fil | Fil: Martinez Gomez, Julia. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Purde, Mette Triin. Medical Research Center; Suiza | |
| dc.description.fil | Fil: Niederer, Rebekka. Medical Research Center; Suiza. Kantonsspital St. Gallen; Suiza | |
| dc.description.fil | Fil: Porsch, Maximilian. Kantonsspital St. Gallen; Suiza | |
| dc.description.fil | Fil: Lichtensteiger, Christa. Kantonsspital St. Gallen; Suiza | |
| dc.description.fil | Fil: Kramer, Rafaela. Universitat Erlangen-Nuremberg; Alemania | |
| dc.description.fil | Fil: Erdmann, Michael. Universitat Erlangen-Nuremberg; Alemania | |
| dc.description.fil | Fil: Schmitt, Christina. Ludwig Maximilians Universitat; Alemania | |
| dc.description.fil | Fil: Heinzerling, Lucie. Ludwig Maximilians Universitat; Alemania. Universitat Erlangen-Nuremberg; Alemania | |
| dc.description.fil | Fil: Abdou, Marie Therese. Kantonsspital St Gallen; Suiza | |
| dc.description.fil | Fil: Karbach, Julia. Krankenhaus Nordwest; Alemania | |
| dc.description.fil | Fil: Schadendorf, Dirk. German Cancer Research Center; Alemania | |
| dc.description.fil | Fil: Zimmer, Lisa. German Cancer Research Center; Alemania | |
| dc.description.fil | Fil: Ugurel, Selma. German Cancer Research Center; Alemania | |
| dc.description.fil | Fil: Klümper, Niklas. Universitat Bonn; Alemania | |
| dc.description.fil | Fil: Hölzel, Michael. Universitat Bonn; Alemania | |
| dc.description.fil | Fil: Power, Laura. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Kreutmair, Stefanie. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Capone, Mariaelena. Istituto Nazionale Tumori; Italia | |
| dc.description.fil | Fil: Madonna, Gabriele. Istituto Nazionale Tumori; Italia | |
| dc.description.fil | Fil: Cevhertas, Lacin. Bursa Uludag University; Turquía. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Heider, Anja. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Amaral, Teresa. University Hospital Tübingen; Alemania. Eberhard Karls Universität Tübingen; Alemania | |
| dc.description.fil | Fil: Hasan Ali, Omar. University of British Columbia; Canadá. Kantonsspital St Gallen; Suiza. Universitat Zurich; Suiza | |
| dc.description.fil | Fil: Bomze, David. Kantonsspital St Gallen; Suiza. Tel Aviv University; Israel | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Núñez, Nicolás; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; et al.; Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors; Cell Press; Med; 4; 2; 2-2023; 113-129 | es |
| dc.identifier.eissn | 2666-6340 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 2666-6359 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/226739 | |
| dc.journal.number | 2 | es |
| dc.journal.pagination | 113-129 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Med | es |
| dc.journal.volume | 4 | es |
| dc.language.iso | eng | es |
| dc.publisher | Cell Press | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.medj.2022.12.007 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2666634022005232 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | BIOMARKERS FOR IMMUNOTHERAPY | es |
| dc.subject | CANCER IMMUNOTHERAPY | es |
| dc.subject | CHECKPOINT BLOCKADE | es |
| dc.subject | IMMUNE-RELATED ADVERSE EVENTS | es |
| dc.subject | TRANSLATION TO PATIENTS | es |
| dc.subject.classification | Inmunología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.9da4c30d-b66a-4101-a5b9-d889daced751_B.pdf
- Tamaño:
- 10.36 MB
- Formato:
- Adobe Portable Document Format